Meeting to be held in New York on October 22 hosted by Piper Sandler.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNYA:
- Promising Developments and Strategic Approaches in Tenaya Therapeutics’ Gene Therapy Programs Drive Buy Rating
- Promising Potential of Tenaya Therapeutics’ TN-201 Gene Therapy in Addressing Pediatric Hypertrophic Cardiomyopathy: Analyst Recommends Buy
- Tenaya Therapeutics presents interim data from MyClimb natural history study
- Promising Advancements and Strategic Approaches Underpin Buy Rating for Tenaya Therapeutics
- Innovative Cardiac Gene Therapy Drives Buy Rating for Tenaya Therapeutics